Cadrenal Therapeutics, Inc. (CVKD) vs Nuvilex Inc. (PMCB)

Cadrenal Therapeutics, Inc. and Nuvilex Inc. are both Biotechnology companies. Nuvilex Inc. is the larger, with a market value of $4.9M against $4.3M — 1.1× the size. Across the 10 metrics below, Nuvilex Inc. leads on 7 and Cadrenal Therapeutics, Inc. on 3.

Valuation

Metric CVKD PMCB Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.82 0.17 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 3.67 0.74
EV/Sales n/m n/m 10.73
Earnings yield (426.09%) (509.84%) (28.84%)
Free cash flow yield (303.35%) (224.12%) (23.03%)

Profitability

Metric CVKD PMCB Biotechnology median
Gross margin 0.00% 95.64% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (275.16%) (58.04%) (57.72%)
Return on assets (199.59%) (50.43%) (49.22%)
Return on invested capital (427.54%) 0.00% 0.00%

Growth

Metric CVKD PMCB Biotechnology median
Revenue growth (TTM) — (71.06%) 5.64%
EPS growth (last fiscal year) 23.94% (186.83%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CVKD PMCB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.73 40.29 4.73
Net debt to EBITDA 0.30 5.41 0.96

Dividend

Metric CVKD PMCB Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric CVKD PMCB Biotechnology median
Market cap 4.29m 4.90m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack